Login Register Cart 0
Generic placeholder image

Applied Drug Research, Clinical Trials and Regulatory Affairs

Editor-in-Chief

ISSN (Print): 2667-3371
ISSN (Online): 2667-338X

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Pediatric Drug-Related Problems in an Indian Tertiary Care Hospital

Author(s): Qaiser Jahan, K. Pallavi, R. Hamshika, Varun Talla, Jupally Venkateshwar Rao and Satyanarayan Pattnaik*

Volume 8, Issue 2, 2021

Published on: 27 November, 2021

Article ID: e291021197487 Pages: 7

DOI: 10.2174/2667337108666211029122255

Price: $65

conference banner
Abstract

Background: Improper drug usages expose patients to drug-related problems (DRPs) and can be the cause of patient morbidity and even mortality, especially frequent in hospitalized patients and pediatric groups.

Objective: The objective of the present study was to identify and assess the drug-related problems in the pediatric department of tertiary care hospitals.

Methods: The cross-sectional, observational study was carried out for six months included pediatric in-patients of age ≤15 years of either gender in pediatric units of tertiary care hospitals of India. The enrolled pediatric patients were observed for any drug-related problem that were further recorded and classified using the DRP registration format taken from Cipolle et al. The assessment of therapy was done by using positional statements from standard organizations and guidelines. Main outcome measure: Incidences of drug-related problems and their assessment and root cause analysis.

Results: A total of 970 DRPs were identified in 296 patients, with an overall incidence of 49.3%. The incidence of DRPs was maximum in the age group of 2-12 years of children (51.2%). Patients who took six or more drugs were around eight (OR:8.41, 95% CI: 5.22 to 13.55) times more likely to have DRPs compared to those patients who took less than six drugs. The incidences of DRPs were more in patients who were hospitalized for ≥ 7 days.

Conclusion: The present study revealed significantly higher incidences of DRPs in hospitalized pediatric patients necessitating the involvement of clinical pharmacists in the pediatric department of tertiary care hospitals.

Keywords: Drug-related problems, pediatrics, hospitalized patients, clinical pharmacist, adverse drug reaction, Indian territory

Graphical Abstract

[1]
de Freitas GRM, Neyeloff JL, Balbinotto Neto G, Heineck I. Drug-related morbidity in Brazil: A cost-of-illness model. Value Health Reg Issues 2018; 17: 150-7.
[http://dx.doi.org/10.1016/j.vhri.2018.07.002] [PMID: 30195236]
[2]
King AM, Danagoulian S, Lynch M, et al. The effect of a medical toxicology inpatient service in an academic tertiary care referral center. J Med Toxicol 2019; 15(1): 12-21.
[http://dx.doi.org/10.1007/s13181-018-0684-2] [PMID: 30353414]
[3]
Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997; 54(5): 554-8.
[http://dx.doi.org/10.1093/ajhp/54.5.554] [PMID: 9066865]
[4]
van den Bemt PM, Egberts TC, de Jong-van den Berg LT, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf 2000; 22(4): 321-33.
[http://dx.doi.org/10.2165/00002018-200022040-00005] [PMID: 10789826]
[5]
Zhu Y, Liu C, Zhang Y, et al. Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China. Int J Clin Pharm 2019; 41(6): 1570-7.
[http://dx.doi.org/10.1007/s11096-019-00922-3] [PMID: 31654364]
[6]
Birarra MK, Heye TB, Shibeshi W. Assessment of drug-related problems in pediatric ward of Zewditu Memorial Referral Hospital, Addis Ababa, Ethiopia. Int J Clin Pharm 2017; 39(5): 1039-46.
[http://dx.doi.org/10.1007/s11096-017-0504-9] [PMID: 28689305]
[7]
Andrade PHS, Lobo IMF, da Silva WB. Risk factors for adverse drug reactions in pediatric inpatients: A cohort study. PLoS One 2017; 12(8): e0182327.
[http://dx.doi.org/10.1371/journal.pone.0182327] [PMID: 28763499]
[8]
Ji HH, Song L, Xiao JW, et al. Adverse drug events in Chinese pediatric inpatients and associated risk factors: A retrospective review using the Global Trigger Tool. Sci Rep 2018; 8(1): 2573.
[http://dx.doi.org/10.1038/s41598-018-20868-2] [PMID: 29416072]
[9]
Leopoldino RD, Santos MT, Costa TX, Martins RR, Oliveira AG. Drug related problems in the neonatal intensive care unit: Incidence, characterization and clinical relevance. BMC Pediatr 2019; 19(1): 134.
[http://dx.doi.org/10.1186/s12887-019-1499-2] [PMID: 31027487]
[10]
AlAzmi A, Ahmed O, Alhamdan H, et al. Epidemiology of preventable drug-related problems (DRPs) among hospitalized children at KAMC-Jeddah: A single-institution observation study. Drug Healthc Patient Saf 2019; 11: 95-103.
[http://dx.doi.org/10.2147/DHPS.S220081] [PMID: 31819660]
[11]
Prot-Labarthe S, Di Paolo ER, Lavoie A, et al. Pediatric drug-related problems: A multicenter study in four French-speaking countries. Int J Clin Pharm 2013; 35(2): 251-9.
[http://dx.doi.org/10.1007/s11096-012-9740-1] [PMID: 23263797]
[12]
Konuru V, Naveena B, Sneha Reddy E, Vivek BC, Shravani G. A prospective study on hospitalization due to drug-related problems in a tertiary care hospital. J Pharm Bioallied Sci 2019; 11(4): 328-32.
[http://dx.doi.org/10.4103/jpbs.JPBS_35_18] [PMID: 31619914]
[13]
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill 1998; pp. 78-9.
[14]
Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990; 24(11): 1093-7.
[http://dx.doi.org/10.1177/106002809002401114] [PMID: 2275235]
[15]
Rashed AN, Wilton L, Lo CCH, Kwong BYS, Leung S, Wong ICK. Epidemiology and potential risk factors of drug-related problems in Hong Kong paediatric wards. Br J Clin Pharmacol 2014; 77(5): 873-9.
[http://dx.doi.org/10.1111/bcp.12270] [PMID: 24868576]
[16]
Nascimento Y, Carvalho W, Acurcio F. Drug-related problems observed in a pharmaceutical care service, Belo Horizonte, Brazil. Braz J Pharm Sci 2009; 45: 321-30.
[http://dx.doi.org/10.1590/S1984-82502009000200018]
[17]
Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: Results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60(9): 651-8.
[http://dx.doi.org/10.1007/s00228-004-0830-4] [PMID: 15568140]
[18]
Tigabu BM, Daba D, Habte B. Drug-related problems among medical ward patients in Jimma university specialized hospital, Southwest Ethiopia. J Res Pharm Pract 2014; 3(1): 1-5.
[http://dx.doi.org/10.4103/2279-042X.132702] [PMID: 24991628]
[19]
Yaffe S, Estabrook RWE, Bouxsein P. Rational therapeutics for infants and children: workshop summary. Washington, DC: National Academy Press 2000.
[20]
Fisher DM, O’Keeffe C, Stanski DR, Cronnelly R, Miller RD, Gregory GA. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57(3): 203-8.
[http://dx.doi.org/10.1097/00000542-198209000-00009] [PMID: 7114542]
[21]
Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther 2014; 19(4): 262-76.
[http://dx.doi.org/10.5863/1551-6776-19.4.262] [PMID: 25762871]
[22]
Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301-6.
[http://dx.doi.org/10.1001/jama.1997.03540280039031] [PMID: 9002492]
[23]
Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci 2009; 12(3): 266-72.
[http://dx.doi.org/10.18433/J35C7Z] [PMID: 20067703]
[24]
Peterson C, Gustafsson M. Characterisation of drug-related problems and associated factors at a clinical pharmacist service- naïve hospital in northern Sweden. Drugs Real World Outcomes 2017; 4(2): 97-107.
[http://dx.doi.org/10.1007/s40801-017-0108-7] [PMID: 28527149]
[25]
Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol 2017; 18(1): 52.
[http://dx.doi.org/10.1186/s40360-017-0157-2] [PMID: 28655357]
[26]
Okumura LM, Silva DM, Comarella L. Relation between safe use of medicines and clinical pharmacy services at pediatric intensive care units. Rev Paul Pediatr 2016; 34(4): 397-402.
[http://dx.doi.org/10.1016/j.rppede.2016.04.001] [PMID: 27578187]
[27]
Rashed AN, Neubert A, Tomlin S, et al. Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. Eur J Clin Pharmacol 2012; 68(12): 1657-66.
[http://dx.doi.org/10.1007/s00228-012-1302-x] [PMID: 22644343]
[28]
Salwe KJ, Kalyansundaram D, Bahurupi Y. A study on polypharmacy and potential drug-drug interactions among elderly patients admitted in department of medicine of a tertiary care hospital in Puducherry. J Clin Diagn Res 2016; 10(2): FC06-10.
[http://dx.doi.org/10.7860/JCDR/2016/16284.7273] [PMID: 27042480]
[29]
Assefa YA, Kedir A, Kahaliw W. Survey on polypharmacy and drug-drug interactions among elderly people with cardiovascular diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia. Integr Pharm Res Pract 2020; 9: 1-9.
[http://dx.doi.org/10.2147/IPRP.S231286] [PMID: 32021833]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy